FDA Communication with States
This section is to be implemented in consultation with the National Association of Boards of Pharmacy (NABP).
In addition, state boards of pharmacy must be notified when the Secretary receives certain state submissions or makes a determination that a compounding pharmacy is acting contrary to section 503A.
- Inter-governmental Working Meeting on Pharmacy Compounding, March 20-21, 2014
- "Dear Colleague” Letter to States (PDF - 1.3MB)